These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Sanfilippo A syndrome: sulfamidase deficiency in cultured skin fibroblasts and liver. Matalon R; Dorfman A J Clin Invest; 1974 Oct; 54(4):907-12. PubMed ID: 4214836 [TBL] [Abstract][Full Text] [Related]
4. [Therapeutic influence on the blood lipids in manifest coronary sclerosis]. Aschenbeck G Rev Bras Med; 1971 Dec; 28(12):653-8. PubMed ID: 4259647 [No Abstract] [Full Text] [Related]
5. Effect of glycosaminoglycans on experimental cholesterol atherogenesis. A morphological approach. Weber G; Fabbrini P; Resi L; Sforza V; Tanganelli P Pharmacol Res Commun; 1979 Apr; 11(4):341-8. PubMed ID: 482320 [No Abstract] [Full Text] [Related]
6. [Effect of gypsozide on the course of experimental cholesterol atherosclerosis in rabbits]. Iatsyno AI Farmakol Toksikol; 1969; 32(6):687-9. PubMed ID: 5393461 [No Abstract] [Full Text] [Related]
7. Effect of colestipol (U-26,597A) on experimental atherosclerosis in rabbits. Kritchevsky D; Kim HK; Tepper SA Proc Soc Exp Biol Med; 1973 Jan; 142(1):185-8. PubMed ID: 4683239 [No Abstract] [Full Text] [Related]
8. [The atherosclerosis inhibiting effect of antibradykinin agent, pyridinolcarbamate, in cholesterol-fed rabbits]. Numano F Nihon Naika Gakkai Zasshi; 1966 Feb; 54(11):1260-75. PubMed ID: 5951216 [No Abstract] [Full Text] [Related]
9. Inhibition of atherosclerosis in cholesterol-fed rabbits by a heparitin sulfate. Preliminary communication. Grossman BJ; Cifonelli JA; Ozoa AK Atherosclerosis; 1971; 13(1):103-9. PubMed ID: 4252017 [No Abstract] [Full Text] [Related]